Peter T Curtin Selected Research

Peter T Curtin Research Topics

3	Blast Crisis (Blast Phase) 01/2024 - 04/2004
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2015 - 12/2006
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2008 - 12/2006
2	Neoplasms (Cancer) 10/2020 - 09/2004
2	Leukemia 10/2020 - 12/2011
1	Disease Progression 01/2024
1	Lymphoma (Lymphomas) 11/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2015
1	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2012
1	Breast Neoplasms (Breast Cancer) 12/2011
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 02/2008
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 02/2008
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2008
1	Anemia 01/2008
1	Fatigue 12/2006
1	Muscle Weakness 12/2006
1	Tumor Lysis Syndrome 09/2004
1	Leukostasis 09/2004
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2004
1	Philadelphia Chromosome 04/2004
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2004

2	Imatinib Mesylate (Gleevec)FDA Link 09/2004 - 04/2004
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2012
1	TransferasesIBA 12/2011
1	HLA-DR Antigens (HLA-DR)IBA 12/2011
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2011
1	fludarabineIBA 02/2008
1	Lenalidomide (CC 5013)FDA Link 01/2008
1	tandutinibIBA 12/2006
1	ElectrolytesIBA 09/2004